{"id":"https://openalex.org/W4361250847","doi":"https://doi.org/10.1158/0008-5472.22366583","title":"Supplementary Figure Legend from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity","display_name":"Supplementary Figure Legend from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361250847","doi":"https://doi.org/10.1158/0008-5472.22366583"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22366583","doi":"https://doi.org/10.1158/0008-5472.22366583","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22366583","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Retargeted_Oncolytic_Measles_Strains_Entering_via_the_EGFRvIII_Receptor_Maintain_Significant_Antitumor_Activity_against_Gliomas_with_Increased_Tumor_Specificity/22366583/1/files/39811628.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Retargeted_Oncolytic_Measles_Strains_Entering_via_the_EGFRvIII_Receptor_Maintain_Significant_Antitumor_Activity_against_Gliomas_with_Increased_Tumor_Specificity/22366583/1/files/39811628.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027021165","display_name":"Cory Allen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cory Allen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013670490","display_name":"Sompong Vongpunsawad","orcid":"https://orcid.org/0000-0001-7520-8728","observed_orcids":["https://orcid.org/0000-0001-7520-8728"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sompong Vongpunsawad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071254876","display_name":"Takafumi Nakamura","orcid":"https://orcid.org/0000-0002-0196-0754","observed_orcids":["https://orcid.org/0000-0002-0196-0754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takafumi Nakamura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082533670","display_name":"C. David James","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. David James","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091653297","display_name":"Mark A. Schroeder","orcid":"https://orcid.org/0000-0003-4924-8990","observed_orcids":["https://orcid.org/0000-0003-4924-8990"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Schroeder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079468607","display_name":"Roberto Cattaneo","orcid":"https://orcid.org/0000-0001-6881-2548","observed_orcids":["https://orcid.org/0000-0001-6881-2548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roberto Cattaneo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069689120","display_name":"Caterina Giannini","orcid":"https://orcid.org/0000-0003-2757-6782","observed_orcids":["https://orcid.org/0000-0003-2757-6782"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caterina Giannini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067871955","display_name":"James Walter Krempski","orcid":"https://orcid.org/0000-0003-4901-5791","observed_orcids":["https://orcid.org/0000-0003-4901-5791"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Krempski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072521252","display_name":"Kah-Whye Peng","orcid":"https://orcid.org/0000-0002-9815-7721","observed_orcids":["https://orcid.org/0000-0002-9815-7721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kah-Whye Peng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012102991","display_name":"Jenny M. Goble","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenny M. Goble","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025687850","display_name":"Joon H. Uhm","orcid":"https://orcid.org/0009-0003-1048-546X","observed_orcids":["https://orcid.org/0009-0003-1048-546X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joon H. Uhm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051470930","display_name":"Stephen J. Russell","orcid":"https://orcid.org/0009-0007-8925-5163","observed_orcids":["https://orcid.org/0009-0007-8925-5163","https://orcid.org/0000-0002-0799-6432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen J. Russell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5017494786","display_name":"Evanthia Galanis","orcid":"https://orcid.org/0000-0001-8014-786X","observed_orcids":["https://orcid.org/0000-0001-8014-786X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evanthia Galanis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-measles-virus","display_name":"oncolytic measles virus","score":0.9729999899864197},{"id":"https://openalex.org/keywords/egfrviii","display_name":"EGFRvIII","score":0.8410000205039978},{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.8669999837875366},{"id":"https://openalex.org/keywords/tumor-specificity","display_name":"tumor specificity","score":0.8119999766349792},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.9316681623458862},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5381821393966675},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5161396265029907},{"id":"https://openalex.org/C2778199166","wikidata":"https://www.wikidata.org/wiki/Q573943","display_name":"Measles virus","level":4,"score":0.44743624329566956},{"id":"https://openalex.org/C2776438120","wikidata":"https://www.wikidata.org/wiki/Q79793","display_name":"Measles","level":3,"score":0.428815633058548},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.41038310527801514},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35409557819366455},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3239905834197998},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.21295157074928284},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15439018607139587},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.08053088188171387}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22366583","doi":"https://doi.org/10.1158/0008-5472.22366583","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22366583","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Retargeted_Oncolytic_Measles_Strains_Entering_via_the_EGFRvIII_Receptor_Maintain_Significant_Antitumor_Activity_against_Gliomas_with_Increased_Tumor_Specificity/22366583/1/files/39811628.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22366583.v1","doi":"https://doi.org/10.1158/0008-5472.22366583.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22366583.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22366583","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Retargeted_Oncolytic_Measles_Strains_Entering_via_the_EGFRvIII_Receptor_Maintain_Significant_Antitumor_Activity_against_Gliomas_with_Increased_Tumor_Specificity/22366583","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22366583","doi":"https://doi.org/10.1158/0008-5472.22366583","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22366583","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Retargeted_Oncolytic_Measles_Strains_Entering_via_the_EGFRvIII_Receptor_Maintain_Significant_Antitumor_Activity_against_Gliomas_with_Increased_Tumor_Specificity/22366583/1/files/39811628.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361250847.pdf","grobid_xml":"https://content.openalex.org/works/W4361250847.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361265434","https://openalex.org/W2091707974","https://openalex.org/W2916100916","https://openalex.org/W2070948297","https://openalex.org/W4236241064","https://openalex.org/W2091102284","https://openalex.org/W4248099837","https://openalex.org/W1963549136","https://openalex.org/W3194827337","https://openalex.org/W4250459567"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"Legend":[2],"from":[3],"Retargeted":[4],"Oncolytic":[5],"Measles":[6],"Strains":[7],"Entering":[8],"via":[9],"the":[10],"EGFRvIII":[11],"Receptor":[12],"Maintain":[13],"Significant":[14],"Antitumor":[15],"Activity":[16],"against":[17],"Gliomas":[18],"with":[19],"Increased":[20],"Tumor":[21],"Specificity":[22]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-31T00:00:00"}